They're not.
Each begins in different cells, behaves differently, and can require very different treatments.
Understanding those differences starts with understanding where blood cells come from.
They All Begin With Blood-Forming or Immune Cells
Most blood cells originate from stem cells in the bone marrow, the soft, spongy tissue inside certain bones.
Those stem cells eventually develop into different types of cells, including red blood cells, platelets, and several types of white blood cells.
Blood cancers develop when one of these cells acquires changes that allow it to grow or survive abnormally.
Which cell becomes abnormal helps determine whether we're dealing with leukemia, lymphoma, myeloma, or another blood cancer.
Leukemia: A Cancer of Blood-Forming Cells
Leukemia usually begins in the bone marrow, where abnormal blood-forming cells multiply and interfere with the production of healthy blood cells.
Unlike many solid cancers, leukemia generally doesn't begin by forming one localized tumor.
There isn't just one leukemia, either.
The major types include:
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
Chronic lymphocytic leukemia (CLL)
Chronic myeloid leukemia (CML)
The words acute and chronic help describe how the disease develops.
Acute leukemias generally involve immature blood-forming cells and can progress rapidly without treatment.
Chronic leukemias usually involve more mature-appearing cells and often progress more slowly, although their behavior varies considerably depending on the specific disease.
As abnormal cells accumulate, they can crowd out healthy cells in the bone marrow. This can contribute to anemia, infections, bruising or bleeding, fatigue, and other symptoms.
Lymphoma: A Cancer of Lymphocytes
Lymphoma primarily develops from lymphocytes, white blood cells that play an important role in the immune system.
The lymphatic system includes lymph nodes, the spleen, thymus, bone marrow, and a network of lymphatic vessels throughout the body.
There are two broad categories:
Hodgkin lymphoma
Non-Hodgkin lymphoma
Hodgkin lymphoma is characterized by particular abnormal cells called Reed-Sternberg cells.
Non-Hodgkin lymphoma isn't one disease. It's a large and diverse group of lymphomas that can develop from different types of lymphocytes, most commonly B cells or T cells.
Some lymphomas grow very slowly and may initially require little or no treatment. Others are aggressive and require treatment quickly.
Swollen lymph nodes are a well-known sign of lymphoma, but lymphoma doesn't always cause noticeable lumps. It can also involve organs such as the spleen, bone marrow, gastrointestinal tract, skin, or other tissues.
Multiple Myeloma: A Cancer of Plasma Cells
Multiple myeloma develops from plasma cells, which are specialized white blood cells that normally produce antibodies to help us fight infections.
Plasma cells primarily live in the bone marrow.
With multiple myeloma, one abnormal plasma cell begins multiplying, creating a clone of cancerous plasma cells.
As those cells accumulate, they can interfere with normal blood-cell production and affect the surrounding bone.
Myeloma can cause problems such as:
Bone lesions and fractures
Anemia and fatigue
Kidney problems
High calcium levels
Weakened immunity and infections
Myeloma cells also commonly produce an abnormal antibody or antibody component known as a monoclonal protein (M-protein) or abnormal free light chains.
These proteins can be measured in the blood or urine in many patients and are an important part of diagnosing and monitoring the disease.
What About Plasmacytoma?
A plasmacytoma is a localized collection of abnormal plasma cells.
A solitary plasmacytoma of bone occurs in one area of bone without the widespread bone marrow findings required for a multiple myeloma diagnosis.
An extramedullary plasmacytoma occurs in soft tissue outside the bone marrow.
Some people diagnosed with a solitary plasmacytoma eventually develop multiple myeloma, which is why continued monitoring is important.
Although multiple myeloma primarily involves the bone marrow, myeloma cells can sometimes grow outside it. This is called extramedullary disease.
So What's the Simplest Difference?
Think about these cancers according to the cells they primarily involve:
Leukemia → blood-forming cells, often in the bone marrow and blood
Lymphoma → lymphocytes, often involving the lymphatic system
Multiple myeloma → plasma cells, primarily involving the bone marrow
But even those descriptions are simplified.
Each category contains multiple diseases and subtypes with different genetic characteristics, symptoms, treatments, and outlooks.
Blood Cancer Doesn't Always Mean a Tumor
One reason blood cancers can be confusing is that they don't always behave like the solid cancers most people are familiar with.
Someone may have a serious blood cancer without ever developing a traditional lump or tumor.
Doctors may instead find abnormalities through blood tests, bone marrow biopsies, lymph-node biopsies, imaging, genetic testing, or specialized laboratory tests.
That's why symptoms such as unexplained fatigue, repeated infections, unusual bruising, swollen lymph nodes, unexplained weight loss, persistent bone pain, or abnormal blood counts sometimes require further investigation.
Different Diseases, One Important Connection
Leukemia, lymphoma, and multiple myeloma all involve cells associated with our blood-forming and immune systems, but that's where their paths begin to separate.
Leukemia isn't lymphoma. Lymphoma isn't myeloma. And myeloma isn't leukemia.
Understanding which cell has become abnormal—and how that particular cancer behaves—is essential because today's blood cancer treatments are increasingly designed around the specific disease and its biology.
They may all fall under the umbrella of blood cancer, but underneath that umbrella are many very different diseases.
Comments
Post a Comment